RK

Rajendra Kachhawa

Active Director Director DIN 02886027
DIN 02886027 First appointment Oct 2009 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Oct 2009
Shareholding value •••• Premium profile

About Rajendra Kachhawa

Data last updated:

Rajendra Kachhawa is a Director at Arth Diagnostic Private Limited (since 2016), Director at Divyansh Medicare Private Limited (since 2021) and Director at Suvidhh Imaging Centre Private Limited (since 2016), and holds 1 more current directorship. The companies operate in Healthcare. The 4 current companies with reported revenue have a combined latest revenue of ₹22.99 Cr; the largest is Arth Diagnostic Private Limited at ₹20.64 Cr (FY 2024). Earlier, Rajendra Kachhawa was a Director at Amolak Diagnostics Private Limited (2009–2011).

DIN 02886027
Primary Designation Director
Industry Healthcare
First Appointment 01 Oct 2009
Oldest Company Age 14 yrs
Largest company Arth Diagnostic Private Limited · ₹20.64 Cr (FY 2024)
Combined revenue ₹22.99 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arth Diagnostic Private Limited U33110RJ2012PTC039217
Director29 Aug 20162012₹20.64 Cr (FY 2024)Active
Divyansh Medicare Private Limited U33110RJ2013PTC044052
Director17 Feb 20212013₹1.63 Cr (FY 2024)Active
Director05 Dec 20162016₹39.6 Lakh (FY 2025)Active
Director09 Sep 20142014₹32 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Amolak Diagnostics Private Limited U85110RJ2006PTC022715
Director01 Oct 20092006Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Divyansh Medicare Private Limited
Raahat Hospital And Medicalcare Private Limited
Suvidhh Imaging Centre Private Limited
Arth Diagnostic Private Limited
Premium access

Shareholding and investment profile for Rajendra Kachhawa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajendra Kachhawa

Rajendra Kachhawa currently holds 4 directorships: Arth Diagnostic Private Limited (Director, since 29 Aug 2016, revenue ₹20.64 Cr (FY 2024)); Divyansh Medicare Private Limited (Director, since 17 Feb 2021, revenue ₹1.63 Cr (FY 2024)); Suvidhh Imaging Centre Private Limited (Director, since 05 Dec 2016, revenue ₹39.6 Lakh (FY 2025)); Raahat Hospital And Medicalcare Private Limited (Director, since 09 Sep 2014, revenue ₹32 Lakh (FY 2025)).

Rajendra Kachhawa was first appointed on 01 Oct 2009 as Director at Amolak Diagnostics Private Limited. The most recent appointment on record is 17 Feb 2021 at Divyansh Medicare Private Limited.

The 4 current companies of Rajendra Kachhawa that report revenue have a combined latest revenue of ₹22.99 Cr: Arth Diagnostic Private Limited ₹20.64 Cr (FY 2024); Divyansh Medicare Private Limited ₹1.63 Cr (FY 2024); Suvidhh Imaging Centre Private Limited ₹39.6 Lakh (FY 2025); Raahat Hospital And Medicalcare Private Limited ₹32 Lakh (FY 2025).

Rajendra Kachhawa held 1 earlier board appointment: Amolak Diagnostics Private Limited (Director, 01 Oct 2009 to 31 Jan 2011).

The current boards of Rajendra Kachhawa's companies include Arvinder Singh (Arth Diagnostic Private Limited), Praveen Kumar Sharma (Arth Diagnostic Private Limited), Satyendra Singh Panwar (Arth Diagnostic Private Limited), Syed Ahmed Khursheed (Arth Diagnostic Private Limited), Milind Poswal (Raahat Hospital And Medicalcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available